Clinical Trials Directory

Trials / Completed

CompletedNCT04286581

Comparison of Ambu Auragain and I-Gel Supraglottic Airways in Adult Patients at an Ambulatory Surgery Center

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
148 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if an I-gel laryngeal mask airway (LMA) has a higher oropharyngeal leak pressure compared to an Ambu Auragain in adult patients in an ambulatory surgery center.

Detailed description

Patients who are scheduled for elective ambulatory surgery under general anesthesia will be randomized to one of two groups. Group 1 will receive an I-gel laryngeal mask airway (LMA) and group 2 will receive an Ambu Auragain LMA.

Conditions

Interventions

TypeNameDescription
DEVICEI-Gel Laryngeal Mask AirwayThe I-Gel Laryngeal Mask Airway is a medical device that keeps a patient's airway open during anaesthesia or unconsciousness.
DEVICEAmbu Auragain Laryngeal Mask AirwayThe Ambu Auragain Laryngeal Mask Airway is a medical device that keeps a patient's airway open during anaesthesia or unconsciousness.

Timeline

Start date
2021-03-22
Primary completion
2021-10-31
Completion
2021-10-31
First posted
2020-02-27
Last updated
2022-12-19
Results posted
2022-12-19

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04286581. Inclusion in this directory is not an endorsement.